Literature DB >> 33522736

Vascular Myelopathies.

Nicholas L Zalewski.   

Abstract

PURPOSE OF REVIEW: Neurologists should be able to identify clinical and neuroimaging features that distinguish vascular disorders from other causes of myelopathy. RECENT
FINDINGS: Although certain clinical features suggest a vascular etiology in acute and chronic myelopathy settings, accurate MRI interpretation within the clinical context is key. Recent studies have shown vascular myelopathies are frequently misdiagnosed as transverse myelitis, and recognition of this diagnostic pitfall is important. Many different vascular mechanisms can cause myelopathy; this article provides a comprehensive review that simplifies disease categories into arterial ischemia, venous congestion/ischemia, hematomyelia, and extraparenchymal hemorrhage.
SUMMARY: It is important to recognize and manage vascular disorders of the spinal cord as significant causes of acute, subacute, and progressive myelopathy.
Copyright © 2021 American Academy of Neurology.

Entities:  

Year:  2021        PMID: 33522736     DOI: 10.1212/CON.0000000000000905

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  4 in total

1.  Progressive Myelopathy With Acute Worsening After Steroids and Lumbar Puncture.

Authors:  Simon Thebault; WooJin Kim; Jeremiah Hadwen; Gregory B Walker; Brian Drake; Tadeu A Fantaneanu
Journal:  Neurohospitalist       Date:  2022-02-10

2.  Spontaneous spinal cord ischemia during COVID-19 infection.

Authors:  Francesco Bax; Gian Luigi Gigli; Francesca Iaiza; Mariarosaria Valente
Journal:  J Neurol       Date:  2021-04-28       Impact factor: 4.849

3.  Acute Venous Congestive Myelopathy in a Patient with Neurosarcoidosis.

Authors:  Nicola Hazel Guy
Journal:  J Neurol Surg Rep       Date:  2022-09-29

4.  Case report: Dueling etiologies: Longitudinally extensive spinal cord lesion mimicking spinal cord infarct with simultaneous positive Lyme serology and amphiphysin antibody.

Authors:  Marianna Kalaszi; Eoghan Donlon; Marzuki Wan Ahmad; Abdirahman Sheikh Mohamed; Peter Boers
Journal:  Front Neurol       Date:  2022-09-13       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.